Literature DB >> 26154890

A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells.

Ummar Raheel1, Muhsin Jamal1, Najam Us Sahar Sadaf Zaidi1.   

Abstract

Dengue virus (DENV) is an arthropod-borne virus, which belongs to the Flaviviridae family, and completes its life cycle in two hosts: humans and mosquitoes. For DENV maturation, the surface pre-membrane (prM) protein is cleaved to form a mature membrane protein (M) by furin, which is a cellular enzyme subsequently releasing the mature virus from the host dendritic cell. The objective of the current study was to inhibit mature DENV isotype 2 (DENV2) by RNA-interference in a Vero-81 cell line. Mature DENV2 was propagated in and isolated from U937 cells expressing dendritic cell-specific intracellular adhesion molecule-3-grabbing non-integrin. Maturation of DENV2 was confirmed by Western blot analysis, where virus stock lacking prM was considered mature. Inhibition studies were carried out by transfection of Vero-81 cells with six synthetic siRNAs along with a control siRNA. Reduction in cellular DENV2 was observed also by focus-reduction assay, immunofluorescence assay (IFA), and real-time quantitative polymerase chain reaction (RT-qPCR). Cells transfected with DENV2SsiRNA2, which was targeting the structural region M of mature DENV2, was able to reduce DENV2 titer by up to 85% in focus reduction assays. A significant reduction in mature DENV2 RNA load was observed by RT-qPCR, confirming the previous findings. IFA also revealed reduced levels of cellular DENV2. These results demonstrated that mature DENV2 can be effectively inhibited by synthetic siRNA targeting the structural region of the genome. Mature DENV2 can be successfully inhibited by siRNAs, and specifically high knock-down efficiency is observed by siRNAs against M region of mature DENV2. This study shows that M represents a potential target for RNAi based inhibitory approaches.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26154890      PMCID: PMC4560859          DOI: 10.1089/vim.2015.0034

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  30 in total

1.  Effect of target secondary structure on RNAi efficiency.

Authors:  Yu Shao; Chi Yu Chan; Anil Maliyekkel; Charles E Lawrence; Igor B Roninson; Ye Ding
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

2.  Structure of the immature dengue virus at low pH primes proteolytic maturation.

Authors:  I-Mei Yu; Wei Zhang; Heather A Holdaway; Long Li; Victor A Kostyuchenko; Paul R Chipman; Richard J Kuhn; Michael G Rossmann; Jue Chen
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

Review 3.  Dengue fever in the Indian Subcontinent: an overview.

Authors:  Ummar Raheel; Muhammad Faheem; Mohammad Nasir Riaz; Naghmana Kanwal; Farakh Javed; Najam us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  J Infect Dev Ctries       Date:  2011-04-26       Impact factor: 0.968

4.  Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

Authors:  Sandesh Subramanya; Sang-Soo Kim; Sojan Abraham; Jiahong Yao; Mukesh Kumar; Priti Kumar; Viraga Haridas; Sang-Kyung Lee; Leonard D Shultz; Dale Greiner; Manjunath N; Premlata Shankar
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

5.  Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.

Authors:  Mark E Beatty; Amy Stone; David W Fitzsimons; Jeffrey N Hanna; Sai Kit Lam; Sirenda Vong; Maria G Guzman; Jorge F Mendez-Galvan; Scott B Halstead; G William Letson; Joel Kuritsky; Richard Mahoney; Harold S Margolis
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

6.  Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking.

Authors:  Hilde M van der Schaar; Michael J Rust; Barry-Lee Waarts; Heidi van der Ende-Metselaar; Richard J Kuhn; Jan Wilschut; Xiaowei Zhuang; Jolanda M Smit
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

Review 7.  Strategies for development of Dengue virus inhibitors.

Authors:  Christian G Noble; Yen-Liang Chen; Hongping Dong; Feng Gu; Siew Pheng Lim; Wouter Schul; Qing-Yin Wang; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2010-01-08       Impact factor: 5.970

8.  Functional importance of dengue virus maturation: infectious properties of immature virions.

Authors:  Izabela A Zybert; Heidi van der Ende-Metselaar; Jan Wilschut; Jolanda M Smit
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

9.  Inhibitory effect of small interfering RNA on dengue virus replication in mosquito cells.

Authors:  Xinwei Wu; Hua Hong; Jinya Yue; Yejian Wu; Xiangzhong Li; Liyun Jiang; Lei Li; Qiaoyan Li; Guoquan Gao; Xia Yang
Journal:  Virol J       Date:  2010-10-14       Impact factor: 4.099

10.  In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.

Authors:  Ruklanthi de Alwis; Martina Beltramello; William B Messer; Soila Sukupolvi-Petty; Wahala M P B Wahala; Annette Kraus; Nicholas P Olivarez; Quang Pham; James D Brien; James Brian; Wen-Yang Tsai; Wei-Kung Wang; Scott Halstead; Srisakul Kliks; Michael S Diamond; Ralph Baric; Antonio Lanzavecchia; Federica Sallusto; Aravinda M de Silva
Journal:  PLoS Negl Trop Dis       Date:  2011-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.